Rapid recruitment of macrophages in interleukin-12-mediated tumour regression

Immunology

Volumn 95, Issue 1, 1998, Pages 156-163

  Ha, S J ^a   Lee, S B ^a   Kim, C M ^b   Shin, H S ^a   Sung, Y C ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Korea Cancer Center Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC G 418; BOVINE SERUM ALBUMIN; CD4 ANTIGEN; CD8 ANTIGEN; DOXYCYCLINE; INTERLEUKIN 12; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATOMA CELL; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE SUBPOPULATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR REGRESSION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOTACTIC FACTORS, MACROPHAGE; DOXYCYCLINE; GENE TRANSFER TECHNIQUES; HISTOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-12; KILLER CELLS, NATURAL; LIVER NEOPLASMS, EXPERIMENTAL; MACROPHAGES, PERITONEAL; MICE; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED BUF; TUMOR CELLS, CULTURED;

EID: 0031711866     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00579.x     Document Type: Article

References (40)

1. KOBAYASHI M., FITZ L., RYAN M. et al. (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170, 827.
2. STERN A.S., PODLASKI F.J., HULMES J.D. et al. (1990) Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 87, 6808.
3. TRINCHIERI G. (1994) Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84, 4008.
4. GUBLER U., CHUA A.O., SCHOENHAUT D.S. et al. (1991) Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 88, 4143.
5. D'ANDREA A., RENGARAJU M., VALIANTE N.M. et al. (1992) Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclcar cells. J Exp Med 176, 1387.
6. + T cells. J Immunol 154, 5071.
7. CHAN S.H., PERUSSIA B., GUPTA J.W. et al. (1991) Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 173, 869.
8. GATELY M.K., DESAI B.B., WOLITZKY A.G. et al. (1991) Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 147, 874.
9. TRINCHIERI G. (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13, 251.
10. TRINICHIERI G. (1993) Interleukin-12 and its role in the generation of TH1 cells. Immunol Today 14, 335.
11. NABORS G.S., AFONSO L.C., FARRELL J.P. & SCOTT P. (1995) Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam. Proc Natl Acad Sci USA 92, 3142.
12. TAHARA H. & LOTZE M.T. (1995) Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer. Gene Ther 2, 96.
13. BRUNDA M.J., LUISTRO L., WARRIER R.R. et al. (1993) Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 178, 1223.
14. NASTALA C.L., EDINGTON H.D., MCKINNEY T.G. et al. (1994) Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J Immunol 153, 1697.
15. NOGUCHI Y., RICHARDS E.C., CHEN Y.T. & OLD L.J. (1995) Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma. Proc Natl Acad Sci USA 92, 2219.
16. CAVALLO F., SIGNORELLI P., GIOVARELLI M. et al. (1997) Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. J Natl Cancer Inst 89, 1049.
17. TAHARA H. 3rd, ZEH H.J., STORKUS W.J. et al. (1994) Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res 54, 182.
18. ZITVOGEL L., COUDERC B., MAYORDOMO J.I., ROBBINS P.D., LOTZE M.T. & STORKUS W.J. (1996) IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo. Ann NY Acad Sci 795, 284.
19. TAHARA H., ZITVOGEL L., STORKUS W.J. 3rd et al. (1995) Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J Immunol 154, 6466.
20. CHEN L., CHEN D., BLOCK E., O'DONNELL M., KUFE D.W. & CLINTON S.K. (1997) Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodinier. J Immunol 159, 351.
21. RAKHMILEVICH A.L., TURNER J., FORD M.J. et al. (1996) Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc Natl Acad Sci USA 93, 6291.
22. TAN J., NEWTON C.A., DJEU J.Y. et al. (1996) Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model. Cancer Res 56, 3399.
23. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547.
24. MANETTI R., PARRONCHI P., GIUDIZI M.G. et al. (1993) Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177, 1199.
25. TANNENBAUM C.S., WICKER N., ARMSTRONG D. et al. (1996) Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. J Immunol 156, 693.
26. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 154, 4333.
27. + αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J Immunol 156, 3366.
28. ZOU J.P., YAMAMOTO N., FUJII T. et al. (1995) Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells. Int Immunol 7, 1135.
29. TSUNG K., MEKO J.B., PEPLINSKI G.R., TSUNG T.L. & NORTON J.A. (1997) IL-12 induces T helper 1-directed antitumor response. J Immunol 158, 3359.
30. PUDDU P., FANTUZZI L., BORGHI P. et al. (1997) IL-12 induces IFN-γ expression and secretion in mouse peritoneal macrophages. J Immunol 159, 3490.
31. FREUNDLIEB S., BENDER G., MULLER G., HILLEN W. & BUJARD H. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766.
32. GOSSEN M. & BUJARD H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89, 5547.
33. CHEN C. & OKAYAMA H. (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7, 2745.
34. KISTNER A., GOSSEN M., ZIMMERMANN F. et al. (1996) Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 93, 10933.
35. BACON K.B., CAMP R.D., CUNNINGHAM F.M. & WOOLLARD P.M. (1988) Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12-hydroxy-5,8,10,14-cicosatetraenoic acid. Br J Pharmacol 95, 966.
36. ZITVOGEL L., TAHARA H., ROBBINS P.D. et al. (1995) Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J Immunol 155, 1393.
37. CARUSO M., PHAM-NGUYEN K., KWONG Y.L. et al. (1996) Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc Natl Acad Sci USA 93, 11302.
38. CUI J., SHIN T., KAWANO T. et al. (1997) Requirement for Valpha 14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623.
39. HIESTER A.A., METCALF D.R. & CAMPBELL P.A. (1992) Interleukin-4 is chemotactic for mouse macrophages. Cell Immunol 139, 72.
40. ALLAVENA P., PAGANIN C, ZHOU D., BIANCHI G., SOZZANI S. & MANTOVANI A. (1994) Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood 84, 2261.